Abstract: A dry etching method includes a first step of adsorbing first radicals into a surface of an etching target, wherein the first radicals are contained in first plasma generated from a plasma generator; and a second step of irradiating ion-beams extracted from second plasma generated from the plasma generator onto the surface of the etching target into which the radicals have been adsorbed, thereby desorbing a surface atomic layer of the etching target, wherein the first step is performed such that: a positive potential greater than a potential of the first plasma is applied to one or two selected from first to third grids, while a ground potential is applied to the rest thereof; and a negative potential equal to or lower than a potential of the third grid is applied to a substrate support structure.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the target cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis. The target cell may be a cancer cell.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a cancer cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the cancer cell, the therapeutic compound ultimately being internalized by the cancer cell via endocytosis.

Abstract: The present invention relates to a recombinant exosome containing hyaluronidase and a use thereof, and more particularly to a recombinant exosome that presents hyaluronidase on its surface and use thereof as an anticancer agent.

Abstract: Provided is a battery assembly including: a battery housing; a battery cell assembly including a plurality of battery cells which are stacked and placed in the housing and are electrically connected; and a heat dissipation resin layer, and the battery assembly has minimized cell damage due to a swelling phenomenon occurring in a battery cell and an improved module life by controlling the physical properties of the low-hardness heat dissipation resin layer.

Abstract: A converter according to one embodiment of the present invention comprises: a converting unit for converting an input voltage into a voltage of a predetermined level; a current sensing unit for sensing an input current of the converting unit; a voltage sensing unit for sensing an output voltage of the converting unit; and a control unit for varying the duty of the converting unit by using the sensed input current and the sensed output voltage.

Abstract: Therapeutic compounds for inhibiting and reducing the expression of cell surface proteins and methods for treating cancer, inflammation, and diabetes using the therapeutic compounds.

Abstract: A circuit for generating auxiliary power according to an embodiment of the present invention comprises: a switching unit including at least one upper switch and at least one lower switch which are rendered conductive in a complementary manner; a resonant converter which converts power input from the switching unit and outputs the converted power; and a rectifier which rectifies an output of the resonant converter to output auxiliary power.

Abstract: The present invention relates to a transcription regulatory biopart based on the 3?-untranslated region and a metabolic flux control method thereof.

Abstract: A unit pixel includes first and second photoelectric conversion units, a first transfer transistor disposed between the first photoelectric conversion unit and a first node, a first capacitor connected to the first node through a first switch transistor, and a second transfer transistor disposed between the second photoelectric conversion unit and the first node. A signal including a first voltage level is applied to the first transfer transistor and the second transfer transistor during a first time interval, a signal including a second voltage level is applied to the first transfer transistor, the second transfer transistor, and the first switch transistor during a second time interval, a signal including a third voltage level is applied to the first transfer transistor during a third time interval, and the signal including the first voltage level is applied to the second transfer transistor and the first switch transistor during a fourth time interval.

Abstract: Provided is a fire prevention apparatus including a switch connected to a battery through a first line, a variable resistor connected to the switch, a fuse connected to the variable resistor and a second line connecting the battery with a device powered from the battery, a sensor configured to sense information about battery fire, and a controller configured to control the switch and the variable resistor based on the information about the battery fire.

Abstract: According to various embodiments, there may be provides a method for detecting an abnormality in battery cell type electrodes, which includes: acquiring a 3-dimensional image by imaging a specimen including one or more battery cell type electrodes; determining an arrangement state of the electrodes of the specimen by processing the 3-dimensional image as an input to one or more determination models comprising a deep learning-based determination model or a rule-based determination model; and detecting an abnormality in the electrodes of the specimen based on determination results for each of one or more determination models, and a device therefor.

Abstract: A sealing apparatus is disclosed. In some implementations, the sealing apparatus includes a process chamber having an internal space, a cell loading portion configured to load a plurality of battery cells and enter the internal space of the process chamber, a plurality of sealing units disposed in the internal space of the process chamber, the plurality of sealing units configured to partially seal the battery cells, respectively, and a driving portion configured to move the plurality of sealing units such that the plurality of sealing units come into contact with the plurality of battery cells, respectively.

Abstract: One embodiment of the present invention provides a method of manufacturing an electronic device using a cyclic doping process including i) an operation of forming a unit transfer thin film including a two-dimensional material on a transfer substrate, ii) an operation of doping the unit transfer thin film in a low-damage doping process, iii) an operation of transferring the unit transfer thin film doped according to the operation ii) on a transfer target substrate, and iv) an operation of repeatedly performing the operations i) to iii) several times to reach a target thickness.

Abstract: An elastic electric contact terminal having a structure capable of preventing cracks in the longitudinal direction of a metal layer as much as possible when pressed from top to bottom is disclosed. The electric contact terminal includes: first and second elastic cores each having an upper wall, a lower wall, and a sidewall connecting the upper wall and the lower wall, and having an opening formed on an opposite side of the sidewall; a heat-resistant polymer film that surrounds the upper wall, lower wall, and opening of each core, and is adhered to at least the upper and bottom surfaces of each core via an elastic adhesive; and a metal layer formed on the outer surface of the polymer film. On a side where the opening is formed, the metal layer of each core is adhered to each other through an adhesive layer.

Abstract: The present invention provides a recombinant exosome and uses thereof. More particularly, the present invention provides a recombinant exosome wherein a phagocytosis promoting protein is presented on the surface of the exosome.

Abstract: A power transmission device for a commercial vehicle having an electric axle, may include a first differential ring gear fixedly mounted on a first rear-wheel driveshaft; a second differential ring gear mounted on a second rear-wheel driveshaft; a propeller shaft, with a first differential drive gear engaged with the first differential ring gear being connected to a front-end portion of the propeller shaft and a second differential drive gear engaged with the second differential ring gear being connected to a rear end portion thereof; a reducer connected to the first differential ring gear or the propeller shaft; and a motor, an output shaft of the motor being connected to an input gear of the reducer.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the target cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis. The target cell may be a cancer cell.

Abstract: The present disclosure relates to a battery module, including a cell assembly including one or more battery cells and a busbar assembly electrically connecting the one or more battery cells, a module case including an opening part at least partially opened on one surface, and forming an accommodating space for accommodating the cell assembly therein through the opening part, a module cover coupled to the module case to close the opening part, and a filling part which is provided between an outside of the busbar assembly and the module case and includes an electrically insulating material, and an assembly method thereof.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the target cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis. The target cell may be a fibrotic cell.